netFormulary NHS
North Staffordshire Joint Formulary
North Staffordshire Clinical Commissioning Group
Stoke-on-Trent Clinical Commissioning Group
 Search
 Formulary Chapter 9: Nutrition and blood - Full Chapter
09.01  Anaemias and some other blood disorders
09.01.01  Iron-deficiency anaemias
09.01.01.01  Oral iron
Ferrous fumarate (Galfer®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Galfer®(ferrous fumarate) 140mg per 5ml syrup
(5ml ≡ 45mg of elemental iron)

 
Link  Medicines For Children: Ferrous fumarate for iron-deficiency anaemia
   
Ferrous gluconate 
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Ferrous gluconate 300mg tablets
(300 mg contains 35 mg iron)

 
   
Ferrous sulfate 
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Ferrous sulfate 200mg tablets
(200 mg is equivalent to 65 mg iron)

Standard release preparations only. 
Modified-release preparations of iron are licensed for once-daily dosage, but have no therapeutic advantage and should not be used.

 
   
09.01.01.01  Iron and folic acid
Pregaday®

View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Ferrous fumarate 322mg/folic acid 350microgram tablets

 
   
09.01.01.01  Compound iron preparations to top
09.01.01.02  Parenteral iron
 note 

Parenteral iron: All injectable forms of Iron including Cosmofer, Venofer, Ferinject and Monofer and any other brands are to per given in hospital only according to the trusts local guidelines.

Ferric carboxymaltose
(Ferinject®)Black Triangle
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

100mg/2ml solution for injection vials

Restriction: For use in renal patients.

Also for use in haematology, gastroenterology & surgery outpatients and day case patients

MHRA advice: Intravenous iron and serious hypersensitivity reactions- strengthened recommendations (Dec 2014)

 
Link  MHRA Guidance on IV Iron preparations
   
Iron dextran (CosmoFer®)Black Triangle
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

100mg/2ml solution for injection Amps

MHRA advice: Intravenous iron and serious hypersensitivity reactions- strengthened recommendations (Dec 2014)

 
Link  MHRA Guidance on IV Iron preparations
   
Iron Isomaltoside (Monofer®)Black Triangle
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

100mg/mL solution for injection vials

MHRA advice: Intravenous iron and serious hypersensitivity reactions- strengthened recommendations (Dec 2014)

 
Link   MHRA Guidance on IV Iron preparations
   
Iron sucrose (Venofer®)Black Triangle
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

100mg/5ml solution for injection vials

MHRA advice: Intravenous iron and serious hypersensitivity reactions- strengthened recommendations (Dec 2014)

 

 
Link  MHRA Guidance on IV Iron preparations
   
09.01.02  Drugs used in megaloblastic anaemias
Folic acid 
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Folic acid 400microgram tablets
Folic acid 5mg tablets
Folic acid 2.5mg/5ml oral solution SF 

 
   
Hydroxocobalamin 
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Hydroxocobalamin 1mg/1ml solution for injection ampoules

 

 
   
09.01.03  Drugs used in hypoplastic, haemolytic, and renal anaemias
Eculizumab (Soliris®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

Restriction: In line with NICE Guidance only

Restriction: In accordance with NHS England prescribing policy

 
Link  NICE HST1: Eculizumab for treating atypical haemolytic uraemic syndrome
   
09.01.03  Erythropoietin
Darbepoetin Alfa (Aranesp®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

Restriction: In line with NICE Guidance only

Restriction: In accordance with NHS England prescribing policy

MHRA/CHM advice: Recombinant human erythropoietins: very rare risk of severe cutaneous adverse reactions (updated January 2018)

MHRA/CHM advice (December 2007) Erythropoietins—haemoglobin concentration

MHRA/CHM advice (December 2007 and July 2008) Erythropoietins—tumour progression and survival in patients with cancer

 
Link  NICE TA323: Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy
   
Epoetin Alfa  (Eprex®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

Restriction: In line with NICE Guidance only

Restriction: In accordance with NHS England prescribing policy

MHRA/CHM advice: Recombinant human erythropoietins: very rare risk of severe cutaneous adverse reactions (updated January 2018)

MHRA/CHM advice (December 2007) Erythropoietins—haemoglobin concentration

MHRA/CHM advice (December 2007 and July 2008) Erythropoietins—tumour progression and survival in patients with cancer

 

 
Link  Can epoetin be used in Jehovah’s Witness patients in accordance with their beliefs?
Link  NICE TA323 Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy
   
Epoetin Beta (NeoRecormon®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

Restriction: In line with NICE Guidance only

Restriction: In accordance with NHS England prescribing policy

MHRA/CHM advice: Recombinant human erythropoietins: very rare risk of severe cutaneous adverse reactions (updated January 2018)

MHRA/CHM advice (December 2007) Erythropoietins—haemoglobin concentration

MHRA/CHM advice (December 2007 and July 2008) Erythropoietins—tumour progression and survival in patients with cancer

 

 
Link  Can epoetin be used in Jehovah’s Witness patients in accordance with their beliefs?
Link  NICE TA323 Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy
   
Epoetin Zeta (Retacrit®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

Restriction: In line with NICE Guidance only

Restriction: In accordance with NHS England prescribing policy

MHRA/CHM advice: Recombinant human erythropoietins: very rare risk of severe cutaneous adverse reactions (updated January 2018)

MHRA/CHM advice (December 2007) Erythropoietins—haemoglobin concentration

MHRA/CHM advice (December 2007 and July 2008) Erythropoietins—tumour progression and survival in patients with cancer

 

 
Link  Can epoetin be used in Jehovah’s Witness patients in accordance with their beliefs?
Link  NICE TA323 Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy
   
09.01.03  Iron overload to top
Desferrioxamine mesilate

View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

500mg powder for solution for injection vials

 
   
09.01.04  Drugs used in autoimmune thrombocytopenic purpura
Eltrombopag olamine
(Revolade®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
CCG
BlueTeq

Restriction: In line with NICE Guidance

 

MHRA/CHM advice: Eltrombopag (Revolade®): reports of interference with bilirubin and creatinine test results (July 2018)

 
Link  NICE TA293: Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura
   
Lusutrombopag (Mulpleo®)Black Triangle
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
CCG
BlueTeq

Restriction: In line with NICE Guidance only

 
Link  NICE TA617: Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure
   
Romiplostim (Nplate®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
CCG
BlueTeq

Restriction: In line with NICE Guidance only

 
Link  NICE TA221: Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura
   
Anagrelide hydrochloride

View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber E

Anagrelide hydrochloride 500microgram capsules

Link to ESCA

 
   
09.01.05  G6PD deficiency
09.01.06  Drugs used in neutropenia
Lenograstim (Granocyte®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

13.4 mega unit vial and pre-filled syringe
33.6 mega unit vial and pre-filled syringe.

Restriction: Specialist use only

Granocyte® solution for injection contains 105 micrograms of lenograstim per 13.4 mega unit vial and 263 micrograms lenograstim per 33.6 mega unit vial.

 
   
09.01.07  Drugs used to mobilise stem cells
Plerixafor (Mozobil®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

24mg/1.2ml solution for injection vials

Restriction: In accordance with NHS England prescribing policy

 
   
09.02  Fluids and electrolytes to top
09.02.01  Oral preparations for fluid and electrolyte imbalance
09.02.01.01  Oral potassium
Potassium chloride 
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Sando-K® (potassium chloride 600mg and potassium bicarbonate 400mg) effervescent tablets

Kay-Cee-L® (potassium chloride) 75mg per 1ml syrup

Potassium chloride MR 600mg tablets (Slow K has been discontinued and the imported products of potassium chloride are costly)

 

 
   
09.02.01.01  Potassium removal
Polystyrene Sulphonate Resins
(Calcium Resonium®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Calcium polystyrene sulfonate 999.34 mg per 1 gram

 
   
Sodium zirconium cyclosilicate
(Lokelma®)Black Triangle
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine

Restriction: In line with NICE Guidance only

 
Link  NICE TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia
   
09.02.01.02  Oral sodium and water
Sodium chloride (Slow Sodium®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Slow Sodium® (sodium chloride) MR 600mg tablets

Each Slow Sodium® tablet contains approximately 10 mmol each of Na+and Cl-; tablets can be crushed before administration.

 
   
09.02.01.02  Oral rehydration therapy (ORT) to top
Oral Rehydration Salts
(Dioralyte®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Dioralyte®oral powder sachets blackcurrant
Dioralyte®oral powder sachets citrus
Dioralyte®oral powder sachets plain

 

Reconstitute 1 sachet with 200mL of water (freshly boiled and cooled for infants); 5 sachets reconstituted with 1 litre of water provide Na+ 60 mmol, K+ 20 mmol, Cl60 mmol, citrate 10 mmol, and glucose 90 mmol.

 
   
09.02.01.03  Oral bicarbonate
Sodium bicarbonate 
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Sodium bicarbonate 500mg capsules

 
   
09.02.02  Parenteral preparations for fluid and electrolyte imbalance
09.02.02.01  Electrolytes and water
09.02.02.02  Plasma and plasma substitutes
09.03  Intravenous nutrition to top
 note 

Prescribers should seek advice from the UHNM Nutrition Team via the hospital switchboard or from the UHNM Pharmacy Manufacturing Department, tel. no. 01782674576

09.04  Oral nutrition
 note 

The guideline for 'Appropriate prescribing of Oral Nutritional Supplements (ONS) in the treatment of Adult Malnutrition in primary care' can be accessed on netFormulary via this link

Prescribers should seek advice from the UHNM Dietetics Department should they require any further information, tel. no. 01782 676030.

Joint Staffordshire CCG's Statement Regarding ONS in Primary Care.

Staffordshire and Stoke-on-Trent CCG's recommend in all cases of Malnutrition:

  1. Appropriate nutritional assessment should be undertaken to assess risk in all patients.
  2. Food fortification or over-the-counter nutritional supplements should be advised as firt-line treatment in patients with low/medium nutritional risk.
  3. For patients at high risk (or those who fail to achieve the target MUST scores after first-line treatment) should be considered for ONS supplements or dietetic referral as detailed in the guidelines.
Ensure Shake (Powdered ONS)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

7 x 57g sachet containing 389kcal and 17g protein when mixed with 200ml whole milk

Available in vanilla, strawberry, chocolate and banana.

 
   
09.04.01  Foods for special diets
09.04.02  Enteral nutrition
09.05  Minerals
09.05.01  Calcium and magnesium to top
09.05.01.01  Calcium supplements
Calcichew ®

View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Calcichew ®Calcium carbonate 1.25g (500mg) tablets (12.6mmol Ca2+)

 
   
Calcium gluconate 
(Injection)
View adult BNF View childrens BNF  Track Changes
Formulary
Red

Calcium gluconate 100mg/1ml (10%) solution for injection ampoules
(1 g contains calcium 89 mg or Ca2+ 2.23 mmol.)

 

The MHRA has advised that repeated or prolonged administration of calcium gluconate injection packaged in 10 mL glass containers is contra-indicated in children under 18 years and in patients with renal impairment owing to the risk of aluminium accumulation; in these patients the use of calcium gluconate injection packaged in plastic containers is recommended.

 
   
Sandocal®1000

View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Calcium carbonate 1.75gram/calcium lactate gluconate 2.263gram effervescent tablets (Each tablet contains 1 g calcium (Ca2+ 25 mmol))

 
   
09.05.01.02  Hypercalcaemia and hypercalciuria
Cinacalcet hydrochloride
(Mimpara®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
NHS England

Cinacalcet 30mg Tablet
Cinacalcet 60mg Tablet
Cinacalcet 90mg Tablet

Restriction: In line with NICE Guidance

 
Link  NICE TA117: Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy
   
Etelcalcetide hydrochloride
(Parsabiv®)Black Triangle
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
NHS England

2.5mg/0.5ml solution for injection vials
5mg/1ml solution for injection vials
10mg/2ml solution for injection vials

Restriction: In line with NICE Guidance

 
Link  NICE TA448: Etelcalcetide for treating secondary hyperparathyroidism
   
09.05.01.03  Magnesium
Magnesium aspartate
(Magnaspartate®)
View adult BNF View childrens BNF  Track Changes
Formulary
Green

Magnesium aspartate 243mg (magnesium 5mmol) oral powder 5g sachets
(contains magnesium aspartate 6.5 g (10 mmol Mg2+)/sachet)

For the acute treatment of mild to moderate hypomagnesaemia. 
For chronic hypomagnesaemia and for maintenance therapy, specialist advice should be sought.

 

 
   
Magnesium sulfate 
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Magnesium sulfate 50% (magnesium 2mmol/ml) solution for injection ampoules

 
   
09.05.02  Phosphorus
09.05.02.01  Phosphate supplements to top
Phosphate-Sandoz®

View adult BNF View childrens BNF  Track Changes
Formulary
Green

Phosphate-Sandoz® Sodium dihydrogen phosphate anydrous 1.936gram effervescent tablets (phosphate 16.1mmol/tablet)

 
   
09.05.02.02  Phosphate-binding agents
Aluminium hydroxide
(Alu-Cap®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Alu-Cap®Aluminium hydroxide 475mg capsules

DISCONTINUED (May 2004)

 
   
Calcium Salts 
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Calcichew ®Calcium carbonate 1.25g (500mg) tablets (12.6mmol Ca2+)
Phosphex®Calcium acetate 1gram tablets (equivalent to 250mg calcium; 6.2 mmol Ca2+)

 
   
Lanthanum carbonate
(Fosrenol®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber E
High Cost Medicine
NHS England

For the treatment of Hyperphosphataemia

Fosrenol®Lanthanum carbonate 500mg chewable tablets
Fosrenol®Lanthanum carbonate 750mg chewable tablets
Fosrenol®Lanthanum carbonate 1gram chewable tablets
Fosrenol®Lanthanum carbonate 750mg oral powder sachets
Fosrenol®Lanthanum carbonate 1gram oral powder sachets

Commissioned by NHS England when used for adult renal dialysis

Link to ESCA

 
   
Sevelamer  
(Prescribe generically)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber E
NHS England

For the treatment of Hyperphosphataemia

Sevelamer 800mg tablets
Sevelamer 2.4g oral sachets - HCD (reserve for patients with swallowing difficulties)

Commissioned by NHS England when used for adult renal dialysis

Link to ESCA

 

 
   
09.05.03  Fluoride
Sodium fluoride 
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Colgate Duraphat® 2800ppm Flouride toothpaste
Colgate Duraphat® 5000ppm Flouride toothpaste
Endekay® Sodium Fluoride Mouthwash 0.05% SF

 

Prescribing responsibility should be retained by dentists for most indications.

Rarely, prescription only tooth preparations may be prescribed in general practice on the recommendation of hospital specialists (e.g as part of a package of care for head and neck cancer) or following diagnosis of an oral condition that would benefit from this treatment

 

Self Care Self Care Medicine-Available OTC for self-care

 

 

 

 

 

 

 

 
   
09.05.04  Zinc
Zinc sulfate (Solvazinc®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Solvazinc®Zinc sulfate monohydrate 125mg effervescent tablets
(contains zinc sulfate monohydrate 125 mg (45 mg zinc))

Please note Valupak Zinc tablets 10mg are available as a food supplement and they are more cost effective but a much lower dose.

Self Care Self Care Medicine-Available OTC for self-care.

 

 
   
09.05.05  Selenium
09.06  Vitamins to top
09.06.01  Vitamin A
 note 

To avoid potential toxicity, the content of all vitamin preparations, particularly vitamin A, should be considered when used together with other supplements.

Vitamins A and D 
View adult BNF View childrens BNF  Track Changes
Formulary
Green

Vitamins A and D (vitamin A 4000unit/vitamin D 400unit) capsules BPC 1973

 
   
Vitamin A palmitate

View childrens BNF  Track Changes
Restricted Drug Restricted
Red

Retinol 50,000units/ml solution for injection vials (Unlicensed, Imported)

 
   
09.06.02  Vitamin B group
Nicotinamide 
 Track Changes
Restricted Drug Restricted
Green

Nicotinamide 500mg Tablets (unlicensed)

 
   
Pyridoxine hydrochloride

View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Pyridoxine hydrochloride 10mg tablets
Pyridoxine hydrochloride 20mg tablets
Pyridoxine hydrochloride 50mg tablets

 

Prolonged use of pyridoxine in a dose of 10 mg daily is considered safe but the long-term use of pyridoxine in a dose of 200  mg or more daily has been associated with neuropathy. The safety of long-term pyridoxine supplementation with doses above 10 mg daily has not been established.

 
   
Thiamine 
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Thiamine 50mg tablets
Thiamine 100mg tablets

 

 

 

 

 
Link  NICE CG100: Alcohol-use disorders: diagnosis and management of physical complications
Link  NICE CG115: Alcohol dependence - diagnosis, assessment and management
   
Vitamin B and C (Pabrinex®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red

Pabrinex® Intramuscular High Potency solution for injection 5ml and 2ml ampoules
Pabrinex® Intravenous High Potency solution for injection 5ml and 5ml ampoules

 

MHRA advice: Pabrinex- allergic reactions (Dec 2014)

 
Link  MHRA Guidance on Pabrinex
Link  NICE CG100: Alcohol-use disorders: diagnosis and management of physical complications
Link  NICE CG115: Alcohol dependence - diagnosis, assessment and management
   
09.06.02  Oral vitamin B complex preparations
Vitamin B compound 
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Vitamin B compound (nicotinamide 15mg/riboflavin 1mg/thiamine hydrochloride 1mg) tablets

HCD - Designated less suitable for prescribing in BNF and high cost. If indicated, consider Vitamin B Compound Strong tablets instead.(Applicable in Primary care only)

 
Link  NICE CG100: Alcohol-use disorders: diagnosis and management of physical complications
   
Vitamin B compound strong

View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Vitamin B compound strong (nicotinamide 20mg/pyridoxine hydrochloride 2mg/riboflavin 2mg/thiamine hydrochloride 5mg) tablets

 

NICE no longer recommends vitamin B Co (strong) for patients with alcohol use disorders (NICE CG100). Clinicians should review use accordingly.

 
Link  NICE CG100: Alcohol-use disorders: diagnosis and management of physical complications
   
09.06.02  Other compounds
09.06.03  Vitamin C to top
Ascorbic acid (Vitamin C)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Ascorbic acid 50mg tablets
Ascorbic acid 100mg tablets
Ascorbic acid 200mg tablets
Ascorbic acid 500mg tablets

 

 
   
09.06.04  Vitamin D
Alfacalcidol 
(1alpha-hydroxycholecalciferol)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

One-Alpha® - Alfacalcidol 2mcg/1ml solution for injection ampoules (0.5ml and 1ml)
One-Alpha® - Alfacalcidol 2mcg/1ml oral drops
Alfacalcidol 250nanogram capsules
Alfacalcidol 500nanogram capsules
Alfacalcidol 1microgram capsules

One drop of alfacalcidol 2 microgram/mL oral drops contains approximately 100 nanograms alfacalcidol.

 

 

 
   
Calcitriol 
(1,25-dihydroxycholecalciferol)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Calcitriol 250nanogram capsules
Calcitriol 500nanogram capsules

 

 
   
Fultium D3®
(Colecalciferol )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

HIGH DOSE BOOST

Fultium D3®Colecalciferol 20,000unit capsules

 
   
Invita D3®
(Colecalciferol )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

HIGH DOSE BOOST

Invita D3®Colecalciferol 25,000unit per 1ml oral solution 
Invita D3®Colecalciferol 50,000unit per 1ml oral solution 

 
   
Plenachol®
(Colecalciferol )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

HIGH DOSE BOOST

Plenachol®Colecalciferol 20,000unit capsules

 
   
Stexerol D3®
(Colecalciferol )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

HIGH DOSE BOOST

Stexerol D3®Colecalciferol 25,000unit tablets 

 
   
Thorens®
(Colecalciferol )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Maintenance dose (without calcium)

Thorens®Colecalciferol 10,000unit/ml drops (1 drop ≡ 200unit Colecalciferol)

 

 

 
   
Desunin®
(Colecalciferol )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Maintenance dose (without calcium)

Desunin®Colecalciferol 400unit tablets

 
   
Fultium D3®
(Colecalciferol )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Maintenance dose (without calcium)

Fultium D3®Colecalciferol 800unit capsules

 
   
Accrete D3®
(Colecalciferol and calcium carbonate)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Maintenance dose (with calcium)

Colecalciferol 10microgram (equivalent to 400unit of vitamin D3) plus Calcium carbonate 1500mg (equivalent to 600mg of elemental calcium) tablets

 

Reserve for patients that cannot tolerate chewable tablets

 
   
Adcal-D3®
(Colecalciferol and calcium carbonate)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Maintenance dose (with calcium)

Colecalciferol 10microgram (equivalent to 400unit of vitamin D3) plus Calcium carbonate 1500mg (equivalent to 600mg of elemental calcium) chewable tablets

 
   
Adcal-D3®
(Colecalciferol and calcium carbonate)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Maintenance dose (with calcium)

Colecalciferol 5microgram (equivalent to 200unit of vitamin D3) plus Calcium carbonate 750mg (equivalent to 300mg of elemental calcium) caplets

 
   
Calceos®
(Colecalciferol and calcium carbonate)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Maintenance dose (with calcium)

Colecalciferol 10microgram (equivalent to 400unit of vitamin D3) plus Calcium carbonate 1250mg (equivalent to 500mg of elemental calcium) chewable tablets

 
   
09.06.05  Vitamin E
Alpha tocopheryl acetate
(Vitamin E)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Alpha tocopheryl acetate 75unit capsules
Alpha tocopheryl acetate 100unit capsules
Alpha tocopheryl acetate 200unit capsules
Alpha tocopheryl acetate 250unit capsules
Alpha tocopheryl acetate 400unit capsules
Alpha tocopheryl acetate 600unit capsules
Alpha tocopheryl acetate 1000unit capsules
Alpha tocopheryl acetate 500mg per 5ml oral suspension

(HCD- Oral suspension reserved for patients with swallowing difficulties as expensive) (Applicable in Primary care only)

 

 

 

 
   
09.06.06  Vitamin K
Phytomenadione (Konakion®MM)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Konakion®MM Phytomenadione 10mg per 1ml solution for injection ampoules (10mg/1ml)

Konakion®MM Paediatric phytomenadione 10mg per 1ml solution for injection ampoules (2mg/0.2ml). This strength is also licensed for oral use.

 

Oral use: For oral administration, oral dispensers are provided in the Konakion MM® paediatric pack. After breaking the ampoule open, 0.2 ml of solution should be withdrawn into the oral dispenser until it reaches the mark on the dispenser (0.2 ml = 2 mg vitamin K). Drop the contents of the dispenser directly into the patient's mouth by pressing the plunger.

 
   
Menadiol sodium phosphate

View adult BNF View SPC online View childrens BNF  Track Changes
Unlicensed Drug Unlicensed
Green

Menadiol Diphosphate 10mg Tablets

Special order

 
   
09.06.07  Multivitamin preparations
Dalivit®drops

View SPC online View childrens BNF  Track Changes
Formulary
Green

Dalivit® oral drops

Not licensed for use in children under 6 weeks.

Contains Vitamins A, B's, C, D. See SPC for full details.
(0.6ml= 14 drops = 5000 units vitamin A)

 
   
Paravit-CF®

 Track Changes
Formulary
Amber

Restriction: Supplementation of Vitamins A, D, E and K for paediatric and adult patients with cystic fibrosis.

Prescribing in primary care to commence once a letter from secondary care is received by the GP recommending that Paravit CF® is commenced, and also detailing which supplements Paravit CF® will be replacing.

Capsules or liquid available

 
   
Vitamin 
View adult BNF View childrens BNF  Track Changes
Formulary
Green

Vitamin capsules BPC (or equivalent)

Multivitamins may be prescribed in the NHS to prevent or treat deficiency but not as dietary supplements.

 
   
09.06.07  Vitamin and mineral supplements and adjuncts to synthetic diets to top
Forceval®

View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Forceval®capsules

Restriction: Only for use in patients who have undergone bariatric surgery

 

 
   
Renavit®

View adult BNF View childrens BNF  Track Changes
Formulary
Amber

Renavit®tablets

Restriction: Only for use in renal failure patients undergoing dialysis

ACBS indication:
Dietary management of water-soluble vitamin deficiency in adults with renal failure on dialysis

 
   
09.07  Bitters and tonics
09.08  Metabolic disorders
09.08.01  Drugs used in metabolic disorders
09.08.01  Wilsons disease
Penicillamine 
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Amber

Penicillamine 125mg tablets
Penicillamine 250mg tablets

 
   
Elosulfase alfa (Vimizim® )Black Triangle
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
High Cost Medicine
NHS England

Elosulfase alfa 5mg/5ml concentrate for solution for infusion vials

 

Restriction: In line with NICE Guidance only

Restriction: In accordance with NHS England prescribing policy

 
Link  NICE HST2: Elosulfase alfa for treating mucopolysaccharidosis type IVa
   
09.08.02  Acute porphyrias to top
09.08.02  Drugs unsafe for use in acute porphyrias
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG
Blueteq
High Cost Drug Approval System

Traffic Light Status Information

Status Description

Red

Medicines that can only be prescribed within Secondary Care. Examples of medicines which fall into this category are: Certain new medicines and new indications for older medicines where there is at present no experience of use in Primary Care. Medicines or dressings not available or prescribable in Primary Care. Where a medicine has been classified as Amber E, but an approved shared-care guideline is not yet available   

Amber

Medicines which can be prescribed within Secondary Care, but are only suitable for prescribing in Primary Care after specialist referral. There is no need for approved shared care guidelines for medicines in this category. This replaces Amber 2 on the North Staffs Formulary.   

Amber E

Medicines which can be prescribed within Secondary Care, but are only considered suitable for prescribing in Primary Care under an approved shared-care agreement (ESCA) or Rationale for Initiation, Continuation and Discontinuation (RICaD). This replaces Amber 1 on the North Staffs Formulary  

Green

Medicines which can be prescribed in either Primary or Secondary Care.  

Grey

These medicines have been reviewed by the New Medicines Committee and the Area Prescribing Committee and found not to be suitable for inclusion in the Joint Formulary. Inadequate or weak evidence for efficacy No clearly defined local need Lack of long term safety data No perceived benefit over established formulary alternatives Prescribers can consider these medicines where formulary alternatives are unsuitable, ineffective or not tolerated.  

netFormulary